Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype
Clinical trial NCT02589145 · TERMINATED
Trial details
- NCT number
- NCT02589145
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-22
- Primary completion
- 2019-04-08
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.